WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Phase 2

Completed

Conditions: Stage II Oropharyngeal Squamous Cell Carcinoma
Stage III Oral Cavity Squamous Cell Carcinoma
Stage IVC Oropharyngeal Squamous Cell Carcinoma
Stage I Oropharyngeal Squamous Cell Carcinoma
Human Papillomavirus Infection
Stage IVA Oral Cavity Squamous Cell Carcinoma
Stage IVB Oropharyngeal Squamous Cell Carcinoma
Stage I Oral Cavity Squamous Cell Carcinoma
Stage II Oral Cavity Squamous Cell Carcinoma
Stage III Oropharyngeal Squamous Cell Carcinoma

Interventions: Biological: Durvalumab
Other: Laboratory Biomarker Analysis
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2016-07-11

Last Posted Date: 2022-05-06

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 17

Registration Number: NCT02827838

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil

Phase 3

Completed

Conditions: Cognitive Dysfunction
Memory Impairment

Interventions: Drug: Donepezil 5 mg
Drug: Placebo

First Posted Date: 2016-07-04

Last Posted Date: 2023-09-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 276

Registration Number: NCT02822573

Locations: 🇺🇸
Illinois CancerCare-Peru, Peru, Illinois, United States
🇺🇸
Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States
🇺🇸
Kaiser Permanente West Los Angeles, Los Angeles, California, United States

and more 275 locations

Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon

Not Applicable

Terminated

Conditions: Peripheral Arterial Disease

Interventions: Device: Lutonix
Device: IN.PACT

First Posted Date: 2016-06-24

Last Posted Date: 2024-10-07

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 35

Registration Number: NCT02812966

Locations: 🇺🇸
Advocate South Suburban Hospital, Hazel Crest, Illinois, United States
🇺🇸
Prairie Education and Research Collaborative, Springfield, Illinois, United States
🇺🇸
Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States

and more 3 locations

Intranasal Insulin and Post-stroke Cognition: A Pilot Study

Phase 2

Completed

Conditions: Stroke

Interventions: Drug: Intranasal saline
Drug: Intranasal Insulin

First Posted Date: 2016-06-23

Last Posted Date: 2021-05-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT02810392

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Understanding and Predicting Breast Cancer Events After Treatment

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Diagnostic Test: Cardiac MRI

First Posted Date: 2016-06-07

Last Posted Date: 2024-11-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 403

Registration Number: NCT02791581

Locations: 🇺🇸
Beaumont Hospital - Farmington Hills, Farmington Hills, Michigan, United States
🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States

and more 63 locations